Action Advanced Health Intelligence (AHI)
Société cotée en bourse. Voici le cours, un aperçu de l'activité et l'essentiel à savoir sur Advanced Health Intelligence en septembre 2026.
Advanced Health Intelligence Limited is an Australia-based company that provides biometric-derived digital healthcare solutions. The Company’s products include Biometric Health Assessment (BHA), FaceScan, and BodyScan. Its BHA delivers preventative healthcare measures and refines risk stratification across populations. Its comprehensive insights cover a range of health vitals and risk predictions, allowing its partners to guide individuals into personalized stepped-care pathways. This includes connecting high-risk individuals to traditional primary care, telehealth, or e-health programs. FaceScan estimates vital signs and predicts the risk of chronic disease on a smartphone or Web browser. FaceScan provides estimated readings on heart rate, respiration rate, blood pressure and more in 30 seconds or less. BodyScan is optimized to run on-device using only a smartphone, to deliver accurate body dimension and composition estimates in 60 seconds or less.
Performance de croissance sur six mois
Aperçu de la performance de l'action
Note des analystes
Analysts recommend holding Advanced Health Intelligence Ltd's stock with a target price of $7.92.
Santé financière
Advanced Health Intelligence Ltd has low revenue and cash flow, indicating potential financial challenges.
Voyez plus d'actions en téléchargeant l'application GRATUITEMENT
Cela ne prend que 60 secondes.
Pourquoi investir avec Nemo ?
Zéro commission
Négociez actions, ETF et plus encore sans commission. Gardez une plus grande part de vos gains.
Fiable et réglementé
Membre du groupe Exinity depuis 2015, au service de plus d'un million de clients dans le monde.